Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sham-Controlled Pilot Trial of Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

NCT05643196 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05643196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sham-Controlled Pilot Trial of Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
April 6, 2023
Completion date
April 1, 2024
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, schizophrenia schizoaffective